![Mark A. Gohr](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark A. Gohr
Director of Finance/CFO at ANTH1, Inc.
Mark A. Gohr active positions
Companies | Position | Start | End |
---|---|---|---|
ANTH1, Inc.
![]() ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Comptroller/Controller/Auditor | 2010-06-16 | - |
Director of Finance/CFO | 2010-06-16 | - | |
Director/Board Member | 2008-07-16 | 2010-06-16 |
Career history of Mark A. Gohr
Training of Mark A. Gohr
The University of Colorado | Graduate Degree |
Hastings College | Undergraduate Degree |
Statistics
International
United States | 4 |
Operational
Comptroller/Controller/Auditor | 1 |
Director/Board Member | 1 |
Director of Finance/CFO | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
ANTH1, Inc.
![]() ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Health Technology |
- Stock Market
- Insiders
- Mark A. Gohr
- Experience